Search Results - "Schrezenmeier, E"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Biomarkers in acute kidney injury – pathophysiological basis and clinical performance by Schrezenmeier, E. V., Barasch, J., Budde, K., Westhoff, T., Schmidt‐Ott, K. M.

    Published in Acta Physiologica (01-03-2017)
    “…Various biomarkers of acute kidney injury (AKI) have been discovered and characterized in the recent past. These molecules can be detected in urine or blood…”
    Get full text
    Journal Article
  2. 2

    Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccination by Bondareva, M., Letz, P., Karberg, K., Schrezenmeier, E., Semin, I., Rincon-Arevalo, H., Dörner, T., Mashreghi, M.F., Stefanski, A.-L., Kruglov, A.A.

    Published in Journal of autoimmunity (01-12-2022)
    “…Systemic vaccination against SARS-CoV-2 elicited high titers of specific antibodies in the blood and in the oral cavity. Preexisting autoimmune diseases, such…”
    Get full text
    Journal Article
  3. 3

    Successful Recovery of Acute Renal Transplant Failure in Recurrent Hepatitis C Virus–Associated Membranoproliferative Glomerulonephritis by Schrezenmeier, E., Wu, K., Halleck, F., Liefeldt, L., Brakemeier, S., Bachmann, F., Kron, S., Budde, K., Duerr, M.

    Published in American journal of transplantation (01-03-2017)
    “…Recurrence of hepatitis C virus (HCV)–associated membranoproliferative glomerulonephritis (MPGN) in the kidney transplant may lead to continuous graft…”
    Get full text
    Journal Article
  4. 4

    Lupus and thrombophilia : Antiphospholipid syndrome by Lettau, M, Schrezenmeier, E V, Specker, C, Dörner, T

    Published in Zeitschrift für Rheumatologie (01-05-2020)
    “…Even early on thromboembolic events were observed in patients with systemic lupus erythematosus (SLE) until the antiphospholipid syndrome (APS) was described…”
    Get full text
    Journal Article
  5. 5

    Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease by Halleck, F., Khadzhynov, D., Schrezenmeier, E., Lehner, L., Budde, K., Staeck, O.

    Published in Transplantation proceedings (01-12-2017)
    “…Cytomegalovirus-negative recipients of kidneys from cytomegalovirus (CMV)-positive donors (D+/R−) are at high risk to develop severe clinical manifestations of…”
    Get full text
    Journal Article
  6. 6

    Immunologic Long-term Outcomes of Living-Related Kidney Transplantations Depending on the Donor-Recipient Relationship by Khadzhynov, D., Halleck, F., Lehner, L., Schmidt, D., Schrezenmeier, E., Budde, K., Staeck, O.

    Published in Transplantation proceedings (01-12-2017)
    “…The aim of this study is to analyze the long-term immunologic outcomes of living-related kidney transplantations depending on the donor-recipient relationship…”
    Get full text
    Journal Article
  7. 7

    Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany by Schrezenmeier, E., Budde, K., Staeck, O., Lehner, L., Duerr, M., Khadzhynov, D., Dörner, T., Halleck, F.

    Published in Transplantation proceedings (01-12-2017)
    “…Rituximab is frequently used in solid organ transplantation off-label, especially in patients with renal allografts. Few data are available on the safety…”
    Get full text
    Journal Article
  8. 8

    Lupus und Thrombophilie: Antiphospholipidsyndrom by Lettau, M., Schrezenmeier, E. V., Specker, C., Dörner, T.

    Published in Zeitschrift für Rheumatologie (01-05-2020)
    “…Zusammenfassung Bereits frühzeitig wurden thrombembolische Ereignisse bei Patienten mit systemischem Lupus erythematodes (SLE) beobachtet, bis in den…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12